166 related articles for article (PubMed ID: 22334969)
1. Bone mineral density trends in Indian patients with hyperthyroidism--effect of antithyroid therapy.
Dhanwal DK; Gupta N
J Assoc Physicians India; 2011 Sep; 59():561-2, 567. PubMed ID: 22334969
[TBL] [Abstract][Full Text] [Related]
2. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease.
Lucidarme N; Ruiz JC; Czernichow P; Léger J
J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822
[TBL] [Abstract][Full Text] [Related]
3. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.
Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada-Charneco M; Lund del Castillo JD
Clin Endocrinol (Oxf); 1997 Sep; 47(3):279-85. PubMed ID: 9373448
[TBL] [Abstract][Full Text] [Related]
4. [Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].
Lupoli GA; Fittipaldi MR; Fonderico F; Panico A; Colarusso S; Di Micco L; Cavallo A; Costa L; Paglione A; Lupoli G
Minerva Endocrinol; 2005 Jun; 30(2):89-94. PubMed ID: 15988404
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism].
Yang LJ; Shen FX; Zheng JC; Zhang HL
Zhongguo Gu Shang; 2012 Feb; 25(2):133-7. PubMed ID: 22577718
[TBL] [Abstract][Full Text] [Related]
6. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
8. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
Pantazi H; Papapetrou PD
J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
[TBL] [Abstract][Full Text] [Related]
9. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
11. Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism.
Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada M; Luna JD; Olea N
J Clin Endocrinol Metab; 1997 Jun; 82(6):1989-94. PubMed ID: 9177418
[TBL] [Abstract][Full Text] [Related]
12. [Changes of bone and mineral metabolism in patients with hyperthyroidism before and after treatment].
Chai R; Ye Z; Zhan Z
Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):682-4. PubMed ID: 11038794
[TBL] [Abstract][Full Text] [Related]
13. Rapid restoration of bone mass after surgical management of hyperthyroidism: A prospective case control study in Southern India.
Karunakaran P; Maharajan C; Mohamed KN; Rachamadugu SV
Surgery; 2016 Mar; 159(3):771-6. PubMed ID: 26582500
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of bone mineral density in hyperthyroid patients before and after medical therapy].
Safi S; Hassikou H; Hadri L; Sbihi A; Kadiri A
Ann Endocrinol (Paris); 2006 Mar; 67(1):27-31. PubMed ID: 16596054
[TBL] [Abstract][Full Text] [Related]
15. [Parathyroid function in hyperthyroidism: implications for bone metabolism and effect of the treatment].
Furlanetto RP; Castro ML; de Mesquita CH; Kasamatsu TS; Vieira JG
Rev Paul Med; 1991; 109(2):55-60. PubMed ID: 1909454
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study.
Osman F; Franklyn JA; Holder RL; Sheppard MC; Gammage MD
J Am Coll Cardiol; 2007 Jan; 49(1):71-81. PubMed ID: 17207725
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus.
Al-Maatouq MA; El-Desouki MI; Othman SA; Mattar EH; Babay ZA; Addar M
Saudi Med J; 2004 Oct; 25(10):1423-7. PubMed ID: 15494815
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density in hyperthyroidism.
Karga H; Papapetrou PD; Korakovouni A; Papandroulaki F; Polymeris A; Pampouras G
Clin Endocrinol (Oxf); 2004 Oct; 61(4):466-72. PubMed ID: 15473879
[TBL] [Abstract][Full Text] [Related]
19. Hypovitaminosis D and bone mineral metabolism and bone density in hyperthyroidism.
Dhanwal DK; Kochupillai N; Gupta N; Cooper C; Dennison EM
J Clin Densitom; 2010; 13(4):462-6. PubMed ID: 20663698
[TBL] [Abstract][Full Text] [Related]
20. Bone changes in hyperthyroidism--a preliminary study.
Chen ST; Huang MJ; Juang JH; Lin JD; Huang BY; Huang HS; Tzen KY
Changgeng Yi Xue Za Zhi; 1990 Dec; 13(4):274-81. PubMed ID: 2282564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
